Shattuck Labs, Inc. Common Stock (STTK) Stock Price

STTKStock

$8.06+722.92%52W

Market Cap$808.93M

P/E—

PEG Ratio—

Div yield—

Beta0.99

STTK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)85.76%

Price vs S&P 500 (4W)12.78%

VGM Score34.78

Book Value / Share (Quarterly)$1.27

P/TBV (Annual)0.58x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)15.44%

Cash Flow / Share (Quarterly)$-0.55

Price vs S&P 500 (YTD)104.48%

Net Profit Margin (TTM)-1005.60%

EPS (TTM)$-0.64

10-Day Avg Trading Volume0.93M

EPS Excl Extra (TTM)$-0.64

Revenue Growth (5Y)-36.82%

EPS (Annual)$-0.70

ROI (Annual)-59.24%

Net Profit Margin (5Y Avg)-5460.38%

Cash / Share (Quarterly)$1.20

Revenue Growth QoQ (YoY)-66.63%

ROA (Last FY)-53.62%

Revenue Growth TTM (YoY)-78.29%

EBITD / Share (TTM)$-0.58

ROE (5Y Avg)-57.74%

Operating Margin (TTM)-1071.60%

Cash Flow / Share (Annual)$-0.63

P/B Ratio6.90x

P/B Ratio (Quarterly)5.06x

Net Income / Employee (Annual)$-1,220,200

EV / Revenue (TTM)571.11x

Net Interest Coverage (TTM)-3.43x

ROA (TTM)-55.75%

EPS Incl Extra (Annual)$-0.70

Current Ratio (Annual)11.70x

Quick Ratio (Quarterly)21.28x

3-Month Avg Trading Volume1.10M

52-Week Price Return722.92%

Revenue / Employee (TTM)$25,000

Tangible BV / Share (Quarterly)$2.65

P/S Ratio (Annual)661.53x

Asset Turnover (Annual)0.01x

52-Week High$8.33

Operating Margin (5Y Avg)-5631.28%

EPS Excl Extra (Annual)$-0.70

CapEx CAGR (5Y)-37.25%

26-Week Price Return97.01%

Quick Ratio (Annual)11.07x

13-Week Price Return29.72%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)22.06x

Enterprise Value$571.11M

Revenue / Share Growth (5Y)-42.92%

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-29.38%

Revenue / Employee (Annual)$25,000

Pretax Margin (Annual)-4880.90%

Cash / Share (Annual)$1.23

3-Month Return Std Dev92.41%

Net Income / Employee (TTM)$-1,246,800

ROE (Last FY)-59.24%

EPS Basic Excl Extra (Annual)$-0.70

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.64

ROI (TTM)-60.73%

P/S Ratio (TTM)661.53x

Pretax Margin (5Y Avg)-5460.38%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$4.16

Price vs S&P 500 (52W)704.61%

Year-to-Date Return116.44%

5-Day Price Return6.04%

EPS Normalized (Annual)$-0.70

ROA (5Y Avg)-51.17%

Net Profit Margin (Annual)-4880.90%

Month-to-Date Return11.74%

Cash Flow / Share (TTM)$-2.14

EBITD / Share (Annual)$-0.69

Operating Margin (Annual)-5150.80%

ROI (5Y Avg)-57.74%

EPS Basic Excl Extra (TTM)$-0.64

P/TBV (Quarterly)0.90x

P/B Ratio (Annual)2.80x

Pretax Margin (TTM)-1005.60%

Book Value / Share (Annual)$1.30

Price vs S&P 500 (13W)26.93%

Beta0.99x

Revenue / Share (TTM)$0.01

ROE (TTM)-60.73%

52-Week Low$0.90

vGradeF

gGradeF

mGradeA

vgmGradeD

STTK Earnings Surprise History

Q2 25-0.24est. -0.24

Q3 25-0.14est. -0.14

Q4 25-0.12est. -0.13

Q1 26-0.13est. -0.13

Q2 26-0.12est. -0.12

STTK Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.07

4.21

4.25

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
STTKShattuck Labs, Inc. Common Stock	F	F	A	$8.06
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Shattuck Labs, Inc. Common Stock

Shattuck Labs develops novel antibody therapeutics for inflammatory and immune-mediated diseases. Its lead program, SL-325, is a potentially first-in-class DR3 antagonist antibody for inflammatory bowel disease, with a pipeline including SL-425 (an extended half-life variant) and bispecific antibodies based on its protein engineering platform.